首页> 外文期刊>BMC Geriatrics >Association of pre-operative medication use with post-operative delirium in surgical oncology patients receiving comprehensive geriatric assessment
【24h】

Association of pre-operative medication use with post-operative delirium in surgical oncology patients receiving comprehensive geriatric assessment

机译:接受综合老年医学评估的手术肿瘤患者的术前用药与术后del妄的关联

获取原文
           

摘要

Background Older patients undergoing surgery tend to have a higher frequency of delirium. Delirium is strongly associated with poor surgical outcomes. This study evaluated the association between pre-operative medication use and post-operative delirium (POD) in surgical oncology patients receiving comprehensive geriatric assessment (CGA). Methods A total of 475 patients who were scheduled for cancer surgery and received CGA from January 2014 to June 2015 were included. Pre-operative medication review through CGA was conducted on polypharmacy (≥5 medications), delirium-inducing medications (DIMs), fall-inducing medications (FIMs), and potentially inappropriate medications (PIMs). POD was confirmed by psychiatric consultation, and DSM-V criteria were used for diagnosing delirium. The model fit of the prediction model was assessed by computing the Hosmer-Lemeshow goodness-of-fit test. Effect size was measured using the Nagelkerke R2. Discrimination of the model was assessed by an analysis of the area under receiver operating curve (AUROC). Results Two models were constructed for multivariate analysis based on univariate analysis; model I included dementia and DIM in addition to age and sex, and model II included PIM instead of DIM of model I. Every one year increase of age increased the risk of POD by about 1.1-fold. DIM was a significant factor for POD after adjusting for confounders (AOR 12.78, 95 % CI 2.83-57.74). PIM was also a significant factor for POD (AOR 5.53, 95 % CI 2.03-15.05). The Hosmer-Lemeshow test results revealed good fits for both models (χ2?=?3.842, p =?0.871 for model I and χ2?=?8.130, p =?0.421 for model II). The Nagelkerke R2 effect size and AUROC for model I was 0.215 and 0.833, respectively. Model II had the Nagelkerke R2effect size of 0.174 and AUROC of 0.819. Conclusions These results suggest that pharmacists’ comprehensive review for pre-operative medication use is critical for the post-operative outcomes like delirium in older patients.
机译:背景技术接受手术的老年患者往往发生ir妄的频率更高。 r妄与手术效果差有关。这项研究评估了接受综合老年医学评估(CGA)的手术肿瘤患者的术前用药与术后del妄(POD)之间的关联。方法纳入2014年1月至2015年6月行CGA手术的475例患者。通过CGA进行的术前药物审查涉及多种药物(≥5种药物),诱导ir妄的药物(DIM),引起跌倒的药物(FIM)和可能不适当的药物(PIM)。经精神科会诊确认POD,并使用DSM-V标准诊断ir妄。预测模型的模型拟合度通过计算Hosmer-Lemeshow拟合优度检验进行评估。使用Nagelkerke R 2 测量效果大小。通过对接收器工作曲线(AUROC)下面积的分析来评估模型的区分性。结果在单因素分析的基础上,建立了两个多元分析模型。除年龄和性别外,模型I还包括痴呆症和DIM,模型II则包括PIM而不是模型I的DIM。年龄每增加1年,POD风险就会增加约1.1倍。调整混杂因素后,DIM是POD的重要因素(AOR 12.78,95%CI 2.83-57.74)。 PIM也是POD的重要因素(AOR 5.53,95%CI 2.03-15.05)。 Hosmer-Lemeshow测试结果表明,这两个模型都非常合适(对于模型I,χ 2 ?=?3.842,p =?0.871,对于模型I,χ 2 ?=?8.130,p对于模型II = 0.421)。模型I的Nagelkerke R 2 效应大小和AUROC分别为0.215和0.833。模型II的Nagelkerke R 2 效应大小为0.174,AUROC为0.819。结论这些结果表明,药剂师对术前用药的全面审查对于老年患者的ir妄等术后结果至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号